Home › Funds › Veradace Capital Management LLC › CYRX
Veradace Capital Management LLC position in CYRX
CRYOPORT INC · Health Care
Veradace Capital Management LLC reported holding 133,607 shares of CYRX (CRYOPORT INC) in its Q2 2026 13F filing — a position valued at US$2.1M, representing 1.96% of its reported portfolio and ranking #11 among its reported holdings. Veradace Capital Management LLC has disclosed CYRX holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Veradace Capital Management LLC's CYRX position evolved
Veradace Capital Management LLC first disclosed a stake in CYRX in Q1 2026 at 28,333 shares (US$235K). The position peaked in Q2 2026 at 133,607 shares, worth US$2.1M. Across 2 filings, Veradace Capital Management LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 133,607 shares valued at US$2.1M — an increase of 105,274 shares quarter over quarter.. Notable position changes include a 372% increase in Q2 2026 (shares rose 11% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 28.33K | $234.60K | New |
| Q2 2026 | 133.61K | $2.10M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CYRX and 13F data
CYRX (CRYOPORT INC) is a Health Care company. 48 other funds we track also report a position in CYRX — the largest reported positions include CADIAN CAPITAL MANAGEMENT, LP (US$45.9M), MAK CAPITAL ONE LLC (US$20.1M), Meros Investment Management, LP (US$11.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CYRX
- CADIAN CAPITAL MANAGEMENT, LP 2.92M sh · $45.85M · Q2 2026
- MAK CAPITAL ONE LLC 1.28M sh · $20.05M · Q2 2026
- Meros Investment Management, LP 743.31K sh · $11.67M · Q2 2026
- BROWN CAPITAL MANAGEMENT LLC 670.06K sh · $10.52M · Q2 2026
- Intrinsic Edge Capital Management LLC 630.00K sh · $9.89M · Q2 2026
- Parkman Healthcare Partners LLC 508.32K sh · $7.98M · Q2 2026
- Lionhunter Capital Management, LLC 480.57K sh · $7.55M · Q2 2026
- Roubaix Capital, LLC 404.78K sh · $6.36M · Q2 2026
More on Veradace Capital Management LLC
FAQ
How long has Veradace Capital Management LLC held CYRX?
Veradace Capital Management LLC has disclosed CYRX holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is Veradace Capital Management LLC's current position in CYRX?
As of Q2 2026, Veradace Capital Management LLC holds 133.61K shares of CYRX (CRYOPORT INC), valued at $2.10M, representing 1.96% of its reported portfolio and ranking #11.
Has Veradace Capital Management LLC been buying or selling CYRX?
In the latest 13F filing (Q2 2026), Veradace Capital Management LLC increased its position in CYRX. The position peaked in Q2 2026 at 133.61K shares.
Which other funds hold CYRX?
Other major institutional holders of CYRX include CADIAN CAPITAL MANAGEMENT, LP, MAK CAPITAL ONE LLC, Meros Investment Management, LP, among 48 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.